Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX)

NCT03994302 is registered in ClinicalTrials.gov with Groupe Hospitalier Pitie-Salpetriere as lead sponsor.

NCT NCT03994302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03994302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX)
Lead sponsor
Groupe Hospitalier Pitie-Salpetriere
Phase
Observational
Overall status
Completed
Start date
June 1, 2019
Completion date
April 8, 2023
Enrollment
2,700 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug event, antiphospholipid syndrome, drug toxicity, immune disease